These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 22029186

  • 21. Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden.
    Graf LL, Welsh CH, Qamar Z, Marlar RA.
    Am J Clin Pathol; 2003 Jan; 119(1):52-60. PubMed ID: 12520697
    [Abstract] [Full Text] [Related]

  • 22. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
    De Stefano V, Leone G.
    Haematologica; 1995 Jan; 80(4):344-56. PubMed ID: 7590506
    [Abstract] [Full Text] [Related]

  • 23. Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism.
    Bergrem A, Dahm AE, Jacobsen AF, Mowinckel MC, Sandvik L, Sandset PM.
    Br J Haematol; 2011 Jul; 154(2):241-7. PubMed ID: 21564075
    [Abstract] [Full Text] [Related]

  • 24. The effect of lupus anticoagulant in the second-generation assay for activated protein C resistance.
    Ragland BD, Reed CE, Eiland BM, Tichenor PH, Hudson CL, Fritsma GA, Adler BK, Marques MB.
    Am J Clin Pathol; 2003 Jan; 119(1):66-71. PubMed ID: 12520699
    [Abstract] [Full Text] [Related]

  • 25. Lupus anticoagulant interference in activated protein C resistance testing: in vitro phenomenon or in vivo pathophysiologic effect?
    Shen YM, Cimo ML, Bai Y, Frenkel E, Sarode R.
    Clin Appl Thromb Hemost; 2011 Jan; 17(6):E190-5. PubMed ID: 21406411
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of smoking as a risk factor for activated protein C resistance during pregnancy.
    Kafkas S, Kalkan U, Bolaman Z, Sanci M, Yüksel H, Odabaşi AR.
    Gynecol Obstet Invest; 2007 Jan; 64(2):89-94. PubMed ID: 17314487
    [Abstract] [Full Text] [Related]

  • 27. Careful selection of sample dilution and factor-V-deficient plasma makes the modified activated protein C resistance test highly specific for the factor V Leiden mutation.
    de Ronde H, Bertina RM.
    Blood Coagul Fibrinolysis; 1999 Jan; 10(1):7-17. PubMed ID: 10070830
    [Abstract] [Full Text] [Related]

  • 28. Laboratory diagnosis of hereditary thrombophilia.
    Michiels JJ, Hamulyák K.
    Semin Thromb Hemost; 1998 Jan; 24(4):309-20. PubMed ID: 9763348
    [Abstract] [Full Text] [Related]

  • 29. Simultaneous detection of FV Q506 and prothrombin 20210 A variation by allele-specific PCR.
    Mitterer M, Lanthaler AJ, Mair W, Giacomuzzi K, Coser P.
    Haematologica; 1999 Mar; 84(3):204-7. PubMed ID: 10189382
    [Abstract] [Full Text] [Related]

  • 30. Haemostatic changes and acquired activated protein C resistance in normal pregnancy.
    Mahieu B, Jacobs N, Mahieu S, Naelaerts K, Vertessen F, Weyler J, Jacquemyn Y, Van der Planken M.
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):685-8. PubMed ID: 17890957
    [Abstract] [Full Text] [Related]

  • 31. Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V pool.
    Thomassen MC, Castoldi E, Tans G, Magdeleyns EJ, Delaunoit C, Debusscher L, Van Assche KJ, Rosing J.
    Haematologica; 2003 Oct; 88(10):1150-6. PubMed ID: 14555311
    [Abstract] [Full Text] [Related]

  • 32. Discrimination between normal wildtype and carriers of coagulation factor V Leiden mutation by the activated protein C resistance test in the presence of factor V deficient plasma.
    Reuner KH, Litfin F, Patscheke H.
    Eur J Clin Chem Clin Biochem; 1997 Jan; 35(1):41-5. PubMed ID: 9156566
    [Abstract] [Full Text] [Related]

  • 33. A protein C pathway (PCP) screening test for the detection of APC resistance and protein C or S deficiencies.
    Haas FJ, van Sterkenburg-Kamp BM, Scheepers HA.
    Semin Thromb Hemost; 1998 Jan; 24(4):355-62. PubMed ID: 9763352
    [Abstract] [Full Text] [Related]

  • 34. Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation.
    Dahlbäck B.
    Semin Thromb Hemost; 1999 Jan; 25(3):273-89. PubMed ID: 10443959
    [Abstract] [Full Text] [Related]

  • 35. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
    Strandberg K, Svensson PJ, Ohlin AK.
    Thromb Res; 2007 Jan; 121(2):145-51. PubMed ID: 17499343
    [Abstract] [Full Text] [Related]

  • 36. [Clinical usefulness of global assays of the anticoagulant pathway of protein C].
    Toulon P.
    Ann Biol Clin (Paris); 2001 Jan; 59(5):545-50. PubMed ID: 11602384
    [Abstract] [Full Text] [Related]

  • 37. [The concomitant presence of prohemorrhagic and thrombophilic changes in coagulation factor V: a severe defect of coagulant activity and homozygote resistance to activated protein C].
    Rossi V, Di Rocco N, Del Sonno C, Crivelli S.
    Ann Ital Med Int; 1999 Jan; 14(2):127-9. PubMed ID: 10399376
    [Abstract] [Full Text] [Related]

  • 38. Plasma homocysteine concentration is not associated with activated protein C resistance in patients investigated for hypercoagulability.
    Zarychanski R, Houston DS.
    Thromb Haemost; 2004 Jun; 91(6):1115-22. PubMed ID: 15175797
    [Abstract] [Full Text] [Related]

  • 39. Pseudo-homozygous activated protein C resistance due to coinheritance of heterozygous factor V Leiden mutation and type I factor V deficiency. Variable expression when analyzed by different activated protein C resistance functional assays.
    Delahousse B, Iochmann S, Pouplard C, Fimbel B, Charbonnier B, Gruel Y.
    Blood Coagul Fibrinolysis; 1997 Nov; 8(8):503-9. PubMed ID: 9491268
    [Abstract] [Full Text] [Related]

  • 40. A simple procedure that increases the specificity of the activated protein C resistance test in samples containing antiphospholipid antibodies.
    Jacobsen EM, Wisløff F.
    Thromb Res; 1997 Jun 01; 86(5):385-91. PubMed ID: 9211629
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.